Skip to main content
×
Home
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 38
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Hadland, Scott E. Knight, John R. and Harris, Sion K. 2015. Medical Marijuana. Journal of Developmental & Behavioral Pediatrics, Vol. 36, Issue. 2, p. 115.


    Bhui, K. Ullrich, S. Kallis, C. and Coid, J. W. 2015. Criminal justice pathways to psychiatric care for psychosis. The British Journal of Psychiatry, Vol. 207, Issue. 6, p. 523.


    Kingdon, D. Taylor, L. Ma, K. and Kinoshita, Y. 2013. Changing name: changing prospects for psychosis. Epidemiology and Psychiatric Sciences, Vol. 22, Issue. 04, p. 297.


    Huizink, Anja C. 2013. Commentary on Degenhardtet al. (2013): Specific effect of adolescent cannabis use on anxiety - tentative explanations. Addiction, Vol. 108, Issue. 1, p. 134.


    Bally, Nathalie Zullino, Daniele and Aubry, Jean-Michel 2014. Cannabis use and first manic episode. Journal of Affective Disorders, Vol. 165, p. 103.


    Ksir, Charles and Hart, Carl L. 2016. Cannabis and Psychosis: a Critical Overview of the Relationship. Current Psychiatry Reports, Vol. 18, Issue. 2,


    Hadland, Scott E. and Harris, Sion K. 2014. Youth marijuana use. Current Opinion in Pediatrics, Vol. 26, Issue. 4, p. 420.


    Manseau, Marc W. and Goff, Donald C. 2015. Cannabinoids and Schizophrenia: Risks and Therapeutic Potential. Neurotherapeutics, Vol. 12, Issue. 4, p. 816.


    Bhavsar, Vishal 2015. Environmental factors, including cannabis, are strongly related to the age of onset and morbidity of schizophrenia. Evidence Based Mental Health, Vol. 18, Issue. 3, p. 84.


    Michaels, Timothy I and Novakovic, Vladan 2015. Can Cannabis Cause Psychosis?. Clinical Neuropharmacology, Vol. 38, Issue. 2, p. 63.


    Ballenger, J.C. 2013. Cannabis, schizophrenia and other non-affective psychoses: 35years of follow-up of a population-based cohort. Yearbook of Psychiatry and Applied Mental Health, Vol. 2013, p. 415.


    Parakh, Preeti and Basu, Debasish 2013. Cannabis and psychosis: Have we found the missing links?. Asian Journal of Psychiatry, Vol. 6, Issue. 4, p. 281.


    Volk, David W. Siegel, Benjamin I. Verrico, Christopher D. and Lewis, David A. 2013. Endocannabinoid metabolism in the prefrontal cortex in schizophrenia. Schizophrenia Research, Vol. 147, Issue. 1, p. 53.


    Hall, Wayne and Degenhardt, Louisa 2014. The adverse health effects of chronic cannabis use. Drug Testing and Analysis, Vol. 6, Issue. 1-2, p. 39.


    Agrawal, Arpana and Lynskey, Michael T. 2014. Cannabis controversies: how genetics can inform the study of comorbidity. Addiction, Vol. 109, Issue. 3, p. 360.


    Zamberletti, Erica Beggiato, Sarah Steardo, Luca Prini, Pamela Antonelli, Tiziana Ferraro, Luca Rubino, Tiziana and Parolaro, Daniela 2014. Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats. Neurobiology of Disease, Vol. 63, p. 35.


    Beaulieu, Pierre Boulanger, Aline Desroches, Julie and Clark, Alexander J. 2016. Medical cannabis: considerations for the anesthesiologist and pain physician. Canadian Journal of Anesthesia/Journal canadien d'anesthésie, Vol. 63, Issue. 5, p. 608.


    Davis, Justin Eyre, Harris Jacka, Felice N Dodd, Seetal Dean, Olivia McEwen, Sarah Debnath, Monojit McGrath, John Maes, Michael Amminger, Paul McGorry, Patrick D Pantelis, Christos and Berk, Michael 2016. A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis. Neuroscience & Biobehavioral Reviews, Vol. 65, p. 185.


    Sarrazin, Samuel Louppe, Florence Doukhan, Raphael and Schürhoff, Franck 2015. A clinical comparison of schizophrenia with and without pre-onset cannabis use disorder: a retrospective cohort study using categorical and dimensional approaches. Annals of General Psychiatry, Vol. 14, Issue. 1,


    Volk, David W. and Lewis, David A. 2016. The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in Schizophrenia. Biological Psychiatry, Vol. 79, Issue. 7, p. 595.


    ×

Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort

  • E. Manrique-Garcia (a1), S. Zammit (a2), C. Dalman (a3), T. Hemmingsson (a4), S. Andreasson (a5) and P. Allebeck (a1)
  • DOI: http://dx.doi.org/10.1017/S0033291711002078
  • Published online: 17 October 2011
Abstract
Background

There is now strong evidence that cannabis use increases the risk of psychoses including schizophrenia, but the relationship between cannabis and different psychotic disorders, as well as the mechanisms, are poorly known. We aimed to assess types of psychotic outcomes after use of cannabis in adolescence and variation in risk over time.

Method

A cohort of 50 087 military conscripts with data on cannabis use in late adolescence was followed up during 35 years with regard to in-patient care for psychotic diagnoses.

Results

Odds ratios for psychotic outcomes among frequent cannabis users compared with non-users were 3.7 [95% confidence interval (CI) 2.3–5.8] for schizophrenia, 2.2 (95% CI 1.0–4.7) for brief psychosis and 2.0 (95% CI 0.8–4.7) for other non-affective psychoses. Risk of schizophrenia declined over the decades in moderate users but much less so in frequent users. The presence of a brief psychosis did not increase risk of later schizophrenia more in cannabis users compared with non-users.

Conclusions

Our results confirm an increased risk of schizophrenia in a long-term perspective, although the risk declined over time in moderate users.

Copyright
Corresponding author
*Address for correspondence: E. Manrique-Garcia, M.D., Karolinska Hospital, Department of Public Health, Norrbacka floor 6, S-17176 Stockholm, Sweden. (Email: edison.manrique-garcia@ki.se)
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

M Arendt , R Rosenberg , L Foldager , G Perto , P Munk-Jorgensen (2005). Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases. British Journal of Psychiatry 187, 510515.

L Arseneault , M Cannon , R Poulton , R Murray , A Caspi , TE Moffitt (2002). Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 325, 12121213.

A Castagnini , GE Berrios (2009). Acute and transient psychotic disorders (ICD-10 F23): a review from a European perspective. European Archives of Psychiatry and Clinical Neuroscience 259, 433443.

K Chen , DB Kandel (1995). The natural history of drug use from adolescence to the mid-thirties in a general population sample. American Journal of Public Health 85, 4147.

AS David , A Malmberg , L Brandt , P Allebeck , G Lewis (1997). IQ and risk for schizophrenia: a population-based cohort study. Psychological Medicine 27, 13111323.

DJ Foti , R Kotov , LT Guey , EJ Bromet (2010). Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization. American Journal of Psychiatry 167, 987993.

W Hall , L Degenhardt (2004). Is there a specific ‘cannabis psychosis’? In Marihuana and Madness (ed. D. Castle and R. Murray ), pp. 89–100. Cambridge University Press: Cambridge.

W Hall , L Degenhardt (2009). Adverse health effects of non-medical cannabis use. Lancet 374, 13831391.

C Henquet , M Di Forti , P Morrison , R Kuepper , RM Murray (2008). Gene–environment interplay between cannabis and psychosis. Schizophrenia Bulletin 34, 11111121.

M Hickman , P Vickerman , J Macleod , J Kirkbride , PB Jones (2007). Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction 102, 597606.

A Johns (2001). Psychiatric effects of cannabis. British Journal of Psychiatry 178, 116122.

M Konings , C Henquet , HD Maharajh , G Hutchinson , J Van Os (2008). Early exposure to cannabis and risk for psychosis in young adolescents in Trinidad. Acta Psychiatrica Scandinavica 118, 209213.

R Kuepper , J van Os , R Lieb , HU Wittchen , M Hofler , C Henquet (2011). Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. British Medical Journal 342, d738.

R MacCoun , P Reuter (1997). Interpreting Dutch cannabis policy: reasoning by analogy in the legalization debate. Science 278, 4752.

A Malmberg , G Lewis , A David , P Allebeck (1998). Premorbid adjustment and personality in people with schizophrenia. British Journal of Psychiatry 172, 308315.

J McGrath , J Welham , J Scott , D Varghese , L Degenhardt , MR Hayatbakhsh , R Alati , GM Williams , W Bor , JM Najman (2010). Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Archives of General Psychiatry 67, 440447.

TH Moore , S Zammit , A Lingford-Hughes , TR Barnes , PB Jones , M Burke , G Lewis (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370, 319328.

RM Murray , PD Morrison , C Henquet , M Di Forti (2007). Cannabis, the mind and society: the hash realities. Nature Reviews Neuroscience 8, 885895.

F Smit , L Bolier , P Cuijpers (2004). Cannabis use and the risk of later schizophrenia: a review. Addiction 99, 425430.

N Solowij , BF Grenyer (2002). Are the adverse consequences of cannabis use age-dependent? Addiction 97, 10831086.

G Thornicroft (1990). Cannabis and psychosis. Is there epidemiological evidence for an association? British Journal of Psychiatry 157, 2533.

J van Os , M Bak , M Hanssen , RV Bijl , R de Graaf , H Verdoux (2002). Cannabis use and psychosis: a longitudinal population-based study. American Journal of Epidemiology 156, 319327.

AR Winstock , C Ford , J Witton (2010). Assessment and management of cannabis use disorders in primary care. BMJ 340, c1571.

S Zammit , P Allebeck , S Andreasson , I Lundberg , G Lewis (2002). Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. British Medical Journal 325, 1199.

S Zammit , TH Moore , A Lingford-Hughes , TR Barnes , PB Jones , M Burke , G Lewis (2008). Effects of cannabis use on outcomes of psychotic disorders: systematic review. British Journal of Psychiatry 193, 357363.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords: